Scott Bruner, CEO of the Alliance for Pharmacy Compounding, says Novo Nordisk and Eli Lilly, manufacturers of Wegovy and Zepbound, are amplifying confusion by asserting that they do not sell their active ingredients to compounders, which implies that even legitimate compounders cant safely buy them
In 2021, Novo Nordiskwhich also markets the GLP-1 receptor agonist semaglutide as Rybelsus for T2Dlaunched two Phase III trials, EVOKE and EVOKE Plus, studying the drug in approximately 3,700 people with early-stage Alzheimers disease
Intestinal infection triggers Parkinsons disease-like symptoms in Pink1 mice
The strongest results were typically seen after many months of treatment rather than during the first few weeks
Uses: Previously used in cardiac surgery